Neurotoxicity associated with the medicinal mushroom product-Diamond Shruumz: A case report
Toxicology Reports December 19, 2024 Elizabeth F. Ebbens, Saralyn R. Williams, Rebecca E. Bruccoleri et al.
A 17-year-old girl who ate a chocolate bar marketed as a medicinal mushroom product developed altered mental status, dilated pupils, salivation, and muscle jerks that did not respond to benzodiazepines. She required a breathing tube but all symptoms resolved within 8 hours, and she was discharged the next day. The product, "Diamond Shruumz," had been recalled because it likely contained muscimol, the main toxin in Amanita muscaria mushrooms. This case shows that unregulated medicinal mushroom supplements can be contaminated with toxic substances, producing a recognizable toxidrome. It is among the first reports of such contamination in a commercially available product.